 |
|
White blood cell uses DNA 'catapult' to fight infection
August 14, 2008Eosiniphils help prevent uncontrolled bacterial invasion
SALT LAKE CITY - U.S. and Swiss scientists have made a breakthrough in understanding how a type of white blood cell called the eosinophil may help the body to fight bacterial infections in the digestive tract, according to research published online this week in Nature Medicine.
Hans-Uwe Simon, from the University of Bern, Switzerland, Gerald J.Gleich, M.D., from the University of Utah School of Medicine, and their colleagues discovered that bacteria can activate eosinophils to release mitochondrial DNA in a catapult-like fashion to create a net that captures and kills bacteria.
"This is a fascinating finding," says Gleich, professor of dermatology and internal medicine at the University of Utah and a co-author of the study. "The DNA is released out of the cell in less than a second."
Eosiniphils, which comprise only 1 to 3 percent of human white blood cells, are known to be useful in the body's defense mechanisms against parasites. But their exact role in the immune system is not clear. Unlike other white blood cells, which are distributed throughout the body, eosinophils are found only in selected areas, including the digestive tract. Mitochondria - often referred to as the power plants of the cell - are components within cells that are thought to descend from ancient bacteria. Although most cellular DNA is contained in the nucleus, mitochondria have their own DNA.
Previous research has shown that eosinophils secrete toxic granule proteins during parasite infections and that these granule proteins kill bacteria. Simon, Gleich, and their colleagues found that when eosinophils are stimulated by infection, such as E. coli, they rapidly secrete mitochondrial DNA. This DNA binds to the granule proteins and forms a net that is able to trap and kill bacteria. The researchers also found higher levels of eosinophils were linked to improved survival and lower numbers of bacteria in the blood of mice with widespread bacterial infections.
The toxic proteins released by eosinophils are not always helpful to the body, however, and can damage nearby tissues. The inflammation in some types of asthma and Crohn's disease, a chronic inflammatory disease of the bowel, is attributed to eosinophils. In fact, Simon and his team first found evidence of these DNA-protein traps in tissue taken from the digestive tracts of people with Crohn's disease.
Earlier studies suggested another type of white blood cell - the neutrophil - also expels DNA and granule proteins to kill bacteria. However, this DNA comes from the nucleus and its release causes the neutrophil to die. The eosinophil is able to survive after expelling its mitochondrial DNA.
The researchers hope to learn more about how eosiniphils expel mitochondrial DNA. They speculate that the explosive mechanism might rely on stored energy, similar to the way plants release pollen into the air. "We don't know how eosinophils are capable of catapulting mitochondrial DNA so quickly," says Gleich.
Future investigation may focus on how this energy is generated and how this new knowledge can be applied to the treatment of bacterial infections and inflammatory diseases related to eosinophils.
University of Utah Health Sciences
"This is a fascinating finding," says Gleich, professor of dermatology and internal medicine at the University of Utah and a co-author of the study. "The DNA is released out of the cell in less than a second."
Eosiniphils, which comprise only 1 to 3 percent of human white blood cells, are known to be useful in the body's defense mechanisms against parasites. But their exact role in the immune system is not clear. Unlike other white blood cells, which are distributed throughout the body, eosinophils are found only in selected areas, including the digestive tract. Mitochondria - often referred to as the power plants of the cell - are components within cells that are thought to descend from ancient bacteria. Although most cellular DNA is contained in the nucleus, mitochondria have their own DNA.
Previous research has shown that eosinophils secrete toxic granule proteins during parasite infections and that these granule proteins kill bacteria. Simon, Gleich, and their colleagues found that when eosinophils are stimulated by infection, such as E. coli, they rapidly secrete mitochondrial DNA. This DNA binds to the granule proteins and forms a net that is able to trap and kill bacteria. The researchers also found higher levels of eosinophils were linked to improved survival and lower numbers of bacteria in the blood of mice with widespread bacterial infections.
The toxic proteins released by eosinophils are not always helpful to the body, however, and can damage nearby tissues. The inflammation in some types of asthma and Crohn's disease, a chronic inflammatory disease of the bowel, is attributed to eosinophils. In fact, Simon and his team first found evidence of these DNA-protein traps in tissue taken from the digestive tracts of people with Crohn's disease.
Earlier studies suggested another type of white blood cell - the neutrophil - also expels DNA and granule proteins to kill bacteria. However, this DNA comes from the nucleus and its release causes the neutrophil to die. The eosinophil is able to survive after expelling its mitochondrial DNA.
The researchers hope to learn more about how eosiniphils expel mitochondrial DNA. They speculate that the explosive mechanism might rely on stored energy, similar to the way plants release pollen into the air. "We don't know how eosinophils are capable of catapulting mitochondrial DNA so quickly," says Gleich.
Future investigation may focus on how this energy is generated and how this new knowledge can be applied to the treatment of bacterial infections and inflammatory diseases related to eosinophils.
University of Utah Health Sciences
Eosinophils Current Events and Eosinophils News RSS$2.9 million Australian study AMAZES asthma researchers
Researchers in the Hunter region are poised to begin the biggest asthma study of its type in the world.
Innate immune system targets asthma-linked fungus for destruction
A new study shows that the innate immune system of humans is capable of killing a fungus linked to airway inflammation, chronic rhinosinusitis and bronchial asthma.
Protein a possible key to allergy and asthma control
Activating a protein found on some immune cells seems to halt the cells' typical job of spewing out substances that launch allergic reactions, a study by Johns Hopkins researchers suggests. The findings could eventually lead to new treatments for allergic reactions ranging from annoying bouts of hay fever to deadly asthma attacks.
Protein a possible key to allergy and asthma control
Activating a protein found on some immune cells seems to halt the cells' typical job of spewing out substances that launch allergic reactions, a study by Johns Hopkins researchers suggests. The findings could eventually lead to new treatments for allergic reactions ranging from annoying bouts of hay fever to deadly asthma attacks.
Antibiotic treatment targets difficult asthma
Hunter researchers have shown that a commonly available antibiotic can improve the quality of life of patients with difficult asthma, and may also generate significant health care savings.
Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
As many as one in four people in westernized countries experience pain or discomfort in their upper abdomen, and physicians have almost nothing to offer except anti-acid medicines, which usually don't work.
Coarse particulate matter in air may harm hearts of asthma sufferers, UNC study finds
Breathing air containing coarse particulate matter such as road or construction dust may cause heart problems for asthma sufferers and other vulnerable populations, according to a new study led by the University of North Carolina at Chapel Hill School of Public Health.
Inhaled steroids help young children breathe but do not prevent chronic asthma
Daily treatment with inhaled corticosteroids can reduce breathing problems in pre-school-aged children at high risk for asthma but they do not prevent the development of persistent asthma in these children.
New treatment for specific type of leukemia
Leukemia - or cancer of the bone marrow - strikes some 700 Belgians each year. Chronic Eosinophilic Leukemia (CEL), a specific form of leukemia, is currently treated with Glivec. However, recent research has shown that prolonged usage can cause resistance to Glivec, rendering this chronic form of leukemia untreatable.
A new view of asthma's cause
A newly recognized type of immune cell may play an important role in causing asthma, perhaps explaining why current therapies sometimes fail, report researchers from Children's Hospital Boston in the March 16th New England Journal of Medicine.
More Eosinophils Current Events and Eosinophils News Articles
 | Eosinophils in Allergy and Inflammation (Clinical Allergy and Immunology, 2) This work presents the proceedings of a conference held at Adare Manor, County Limerick, Ireland. It provides an updated, in-depth review of the biological role of eosinophils in allergic diseases, summarizing basic knowledge of these unique cationic proteins. The book features an annotated discussion of the conference's post-presentation question-and-answer... |
| Eosinophil in Health and Disease by Mahmoud | |
 | Eosinophils - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References by ICON Health Publications In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and... |
| Regulation of Human Eosinophil Transmigration Across Lung Epithelium (Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1044) by Lixin Liu | |
 | Human Eosinophils: Biologic and Clinical Aspects (Chemical Immunology) Eosinophils represent approximately 1 per cent of peripheral blood leukocytes and play a central proinflammatory and immunoregulatory role in various immune disorders. This volume provides the reader with a comprehensive survey of the major aspects of human eosinophilic biology and immunology as well as the most clinically relevant aspects of eosinophil-related disorders. Expert contributions... |
| Immunopharmacology of Eosinophils (The Handbook of Immunopharmacology) The eosinophil was identified more than a century ago, and at first dismissed as, at best, just another polymorphonuclear cell. Later, it was considered to play a pivotal role in countering the potentially damaging effects of mast cell degranulation via the production of neutralizing enzymes. Reappraisal followed with the demonstration of toxic effects of the eosinophil's cationic proteins.... | |
 | Eosinophils in Allergy and Related Diseases: Proceedings of a Workshop Tokyo, Japan, June 16, 2001 (Supplement Issue: International Archives of Allergy and Immunology 2002, 1) by Sohei Makino, Takeru Ishikawa, Takeshi Fukuda, Ken Ohta, Itsuo Iwamoto, Takao Fujisawa |
| The mast-cell system,: Its relationship to atherosclerosis, fibrosis and eosinophils by Michel Fernex | |
| Modulation of Human Eosinophil Migration by Rene C Schweizer | |
| Eosinophils in Allergy and Related Diseases: Workshop, Tokyo, June 2005, Proceedings (International Archives of Allergy and Immunology) |
| © 2008 BrightSurf.com |